174 related articles for article (PubMed ID: 22395523)
41. Two cases of concomitant acquired aplastic anemia and systemic mastocytosis.
Golardi N; Sramek JE; Myers JB; Saffer H; George TI; Czuchlewski DR
Hum Pathol; 2014 Feb; 45(2):417-20. PubMed ID: 24182560
[TBL] [Abstract][Full Text] [Related]
42. Pathogenesis, clinical features, and treatment advances in mastocytosis.
Pardanani A; Akin C; Valent P
Best Pract Res Clin Haematol; 2006; 19(3):595-615. PubMed ID: 16781490
[TBL] [Abstract][Full Text] [Related]
43. Systemic Mastocytosis and Essential Thrombocythemia: Case Report and Literature Overview.
Cancian M; Cosi E; Pizzi M; Giannini S; Bertozzi I; Fabris F; Randi ML
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31450655
[TBL] [Abstract][Full Text] [Related]
44. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
45. [Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].
Brière J
Bull Acad Natl Med; 2007 Mar; 191(3):535-48. PubMed ID: 18072652
[TBL] [Abstract][Full Text] [Related]
46. "Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.
Sotlar K; Saeger W; Stellmacher F; Stahmer J; Jäckle S; Valent P; Horny HP
J Clin Pathol; 2006 Aug; 59(8):875-8. PubMed ID: 16873565
[TBL] [Abstract][Full Text] [Related]
47. Detection of phospho-STAT5 in mast cells: a reliable phenotypic marker of systemic mast cell disease that reflects constitutive tyrosine kinase activation.
Zuluaga Toro T; Hsieh FH; Bodo J; Dong HY; Hsi ED
Br J Haematol; 2007 Oct; 139(1):31-40. PubMed ID: 17662084
[TBL] [Abstract][Full Text] [Related]
48. [Systemic mastocytosis: bone impact].
Spivacow FR; Sarli M; Nakutny R
Medicina (B Aires); 2012; 72(3):201-6. PubMed ID: 22763156
[TBL] [Abstract][Full Text] [Related]
49. Systemic mastocytosis with plasma cell dyscrasia: report of a case.
Pullarkat ST; Sedarat F; Paquette R; Said J
Leuk Res; 2008 Jul; 32(7):1160-3. PubMed ID: 18061667
[TBL] [Abstract][Full Text] [Related]
50. Ph-Chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis.
Agis H; Sotlar K; Valent P; Horny HP
Leuk Res; 2005 Oct; 29(10):1227-32. PubMed ID: 16111540
[TBL] [Abstract][Full Text] [Related]
51. Aggressive systemic mastocytosis complicated by protein-losing enteropathy.
Mickys U; Barakauskiene A; De Wolf-Peeters C; Geboes K; De Hertogh G
Dig Liver Dis; 2007 Jul; 39(7):693-7. PubMed ID: 16843741
[TBL] [Abstract][Full Text] [Related]
52. Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immunohistochemical and molecular findings on routinely processed bone marrow biopsy specimens.
Horny HP; Lange K; Sotlar K; Valent P
J Clin Pathol; 2003 Aug; 56(8):575-8. PubMed ID: 12890804
[TBL] [Abstract][Full Text] [Related]
53. Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centre.
Hermans MAW; Rietveld MJA; van Laar JAM; Dalm VASH; Verburg M; Pasmans SGMA; Gerth van Wijk R; van Hagen PM; van Daele PLA
Eur J Intern Med; 2016 May; 30():25-30. PubMed ID: 26809706
[TBL] [Abstract][Full Text] [Related]
54. Systemic mastocytosis in association with chronic lymphocytic leukemia: a rare diagnosis.
Ault P; Lynn A; Tam CS; Medeiros LJ; Keating MJ
Leuk Res; 2007 Dec; 31(12):1755-8. PubMed ID: 17521719
[TBL] [Abstract][Full Text] [Related]
55. Systemic mastocytosis: progressive evolution of an occult disease into fatal mast cell leukemia: unique findings on an unusual hematological neoplasm.
Gülen T; Sander B; Nilsson G; Palmblad J; Sotlar K; Horny HP; Hägglund H
Med Oncol; 2012 Dec; 29(5):3540-6. PubMed ID: 22661384
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
[TBL] [Abstract][Full Text] [Related]
57. Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
Marbello L; Anghilieri M; Nosari A; Minola E; Cairoli R; Ricci F; Morra E
Haematologica; 2004 Sep; 89(9):ECR35. PubMed ID: 15377487
[TBL] [Abstract][Full Text] [Related]
58. Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management.
Crupi F; Sordi B; Vanderwert F; Gesullo F; Amorosi A; Mannelli F; Santi R
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955907
[TBL] [Abstract][Full Text] [Related]
59. Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disease.
Hauswirth AW; Födinger M; Fritz M; Müllauer L; Simonitsch-Klupp I; Streubel B; Chott A; Sperr WR; Jäger U; Valent P
Hum Pathol; 2008 Jun; 39(6):917-24. PubMed ID: 18448146
[TBL] [Abstract][Full Text] [Related]
60. Systemic mastocytosis.
George TI; Horny HP
Hematol Oncol Clin North Am; 2011 Oct; 25(5):1067-83, vii. PubMed ID: 22054735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
